文献速递肿瘤 PET/CT

18F-FDG PET/CT生物学参数对宫颈癌患者总生存期的影响

Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients.
PubMed 文献 · Clin Nucl Med · 2019-01-01

该回顾性研究纳入371例初诊宫颈癌患者,分析原发灶及转移灶的PET代谢参数对总生存期(OS)的影响。PET/CT分期将患者分为仅宫颈、区域淋巴结、远处转移三组,5年生存率分别为86%、80%、55%。Cox回归显示原发灶异质性、SUVtotal和MTVtotal是OS的独立预后因素。

要点

  • PET/CT分期显著影响宫颈癌生存,远处转移组5年生存率仅55%。
  • 原发灶异质性、SUVtotal和MTVtotal是OS独立预后因素。
  • 异质性0.18、SUVtotal 52.3、MTVtotal 66.55 cm为不良预后切点。

核心结论

  • PET/CT评估的疾病分期显著影响宫颈癌患者生存率。
  • 原发灶SUVtotal、MTVtotal和异质性是OS的独立预后因素。

研究设计与样本

  • 回顾性分析371例初诊且组织学确诊的宫颈癌患者。
  • 分析原发灶SUVmax、SUVmean、TLG、MTV、异质性及全身SUVtotal、TLGtotal、MTVtotal。

主要发现

  • 基于PET/CT分为仅宫颈组(38%)、区域淋巴结组(36%)、远处转移组(26%)。
  • 三组5年生存率分别为86%、80%、55%。
  • 异质性均值0.25±0.04 vs 0.16±0.09(P<0.001),SUVtotal 76.6±130.1 vs 45.4±73.4(P=0.002),MTVtotal 79.03±88.27 vs 63.00±83.80 cm(P=0.03)。

关键数值与推荐

  • 异质性不良预后切点为0.18。
  • SUVtotal不良预后切点为52.3。
  • MTVtotal不良预后切点为66.55 cm。

临床怎么用

  • 可利用18F-FDG PET/CT代谢参数对宫颈癌患者进行预后分层。
  • 关注原发灶异质性、SUVtotal和MTVtotal以识别高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The aim of this study was to estimate the influence of biological parameters assessed in [F]FDG PET/CT on overall survival (OS) in cervical cancer patients. METHODS: Retrospective analysis was performed on a group of 371 patients with newly diagnosed and histologically confirmed cervical cancer. PET biological parameters in primary tumor including SUVmax, SUVmean, total lesion glycolysis (TLG), metabolic tumor volume (MTV), heterogeneity, and parameters referring both to primary tumor and metastatic lesions: SUVtotal, TLGtotal, and MTVtotal, were analyzed. RESULTS: Based on PET/CT results, 3 subgroups were identified: cervical only-with disease limited only to the cervix (38%), +regional nodes-where increased glucose accumulation in addition to the cervical area was also observed in regional lymph nodes (36%), and +distal metastases-where PET scan showed a disseminated disease (26%). Depending on the stage of the disease, in the cervical-only group, 5-year survival rate was 86%; in the +regional nodes group, it was 80%; whereas in the +distal metastases group, 5-year survival rate was only 55%. However, based on Cox regression model, significant influence on OS was found only in heterogeneity of primary tumor; more inhomogeneous tumors suggest worse prognosis (0.25 ± 0.04 vs 0.16 ± 0.09, P < 0.001), SUVtotal (76.6 ± 130.1 vs 45.4 ± 73.4, P = 0.002), and MTVtotal (79.03 ± 88.27 vs 63.00 ± 83.80 cm, P = 0.03). For heterogeneity, cutoff point suggesting worse prognosis was 0.18; for SUVtotal, 52.3; and for MTVtotal, 66.55 cm. CONCLUSIONS: Stage of disease assessed in [F]FDG PET/CT significantly influences survival rate in patients with cervical cancer. SUVtotal, MTVtotal, and heterogeneity of primary tumor are independent prognostic factors on OS in cervical cancer patients.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Cegla P, Burchardt E, Roszak A, et al. Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients. Clin Nucl Med. 2019. PMID: 31348081. doi:10.1097/RLU.0000000000002733

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。